Modelling of Cordycepin Production by an Engineered Aspergillus oryzae Under Different Substrates

Given the therapeutic potential of bioactive cordycepin in medical and healthcare products, precision fermentation using an engineered strain of Aspergillus oryzae was performed to enhance cordycepin production. To understand and predict the dynamics of cell growth and cordycepin production in this fungal strain, mathematical modeling of submerged fermentation was applied. The effects of different nitrogen sources (yeast extract, peptone, (NH4)2SO4, NH4Cl, NaNO3, and KNO3) and carbon sources (glucose and cassava starch hydrolysate, CSH) on cell growth and cordycepin production were evaluated under submerged fermentation conditions. The results showed that organic nitrogen sources significantly enhanced biomass formation and cordycepin production compared with inorganic nitrogen sources. Among them, yeast extract provided the best performance, yielding the highest biomass (13.63–15.99 g/L) and cordycepin titer (1.24–1.72 g/L). In contrast, nitrate-based nitrogen sources supported cell growth but resulted in negligible cordycepin production. Under optimized conditions in a bioreactor, both glucose and CSH supported fungal growth, although CSH promoted higher biomass formation while glucose favored cordycepin biosynthesis. The kinetic model demonstrated that the growth of engineered A. oryzae was well described by the logistic growth model (R2 > 0.88). The cordycepin production profiles were well fitted by the Luedeking–Piret model (R2 > 0.99), indicating a mixed growth-associated product with kinetic constants α and β representing growth-associated and non-growth-associated production, respectively. Overall, the developed kinetic model provides a quantitative framework for describing cell growth, substrate utilization, and cordycepin formation, offering guidance for process optimization and scale-up of cordycepin production in engineered fungal systems.